Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study

BACKGROUND: Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) 100/62.5/25 μg has been shown to improve lung function and health status, and reduce exacerbations, versus budesonide/formoterol in patients with chronic obstructive pulmonary disease (COPD). We evaluated the non-inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Bremner, Peter R., Birk, Ruby, Brealey, Noushin, Ismaila, Afisi S., Zhu, Chang-Qing, Lipson, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785849/
https://www.ncbi.nlm.nih.gov/pubmed/29370819
http://dx.doi.org/10.1186/s12931-018-0724-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785849/
https://www.ncbi.nlm.nih.gov/pubmed/29370819
http://dx.doi.org/10.1186/s12931-018-0724-0

Ejemplares similares